Medicare AdvantageCoverageMedium impact
MA06.002c, In Vitro Allergy Testing
Independence Blue Cross·Allergy & Immunology, Family Medicine, Internal Medicine +1 more·Medical Policy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.002c for In Vitro Allergy Testing has been reissued and will take effect on May 28, 2025. This is a fresh policy update that may contain changes to coverage criteria, billing requirements, or prior authorization rules for allergy testing procedures.
Action Required
By May 28, 2025: Billing team must review the complete MA06.002c policy document at the provided URL to identify specific changes to in vitro allergy testing requirements. Update billing procedures, prior authorization protocols, and staff training based on the new policy requirements. Verify current billing practices align with updated coverage criteria.